Gene therapy medicinal products for rare ophthalmological diseases
Horama has raised €4.0M across 1 funding round from 2 investors, most recently a Series A round in Jul 2016. Based in Paris, France; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-07-01 | Series A | €4.0M |
| GO Capital,Omnes Venture Capital |
| View deal → |
